Oncology Clinical Trials in Stony Brook, NY

As of August 2026, 53 paid clinical trials are recruiting for Oncology in Stony Brook, New York. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 31, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

53 clinical trials for Oncology

·Clear filters·

Email me when a new oncology trial opens in Stony Brook, NY.

Raman Spectroscopy and Skin Cancer

for Skin Cancer

1 location in Stony Brook

Sponsor: Tiezhi Zhang

Sex: All·Age: 18+

Code: NCT06384924·Recruiting·Listed Apr 2024

Apply to this trial

Definitive Radiation Therapy for Inoperable Breast Cancer

for Breast Cancer

1 location in Stony Brook

Sponsor: Alexander Stessin

Sex: Female·Age: 18+

Code: NCT07122713·Recruiting·Listed Aug 2025

Apply to this trial

Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme

for Glioblastoma Multiforme

Drug: Atezolizumab

1 location in Stony Brook

Sponsor: Stony Brook University

Sex: All·Age: 18+

Code: NCT05423210·EARLY_Phase 1·Recruiting·Listed Jun 2022

Apply to this trial

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

for Hodgkin Lymphoma in Remission

Sites in Stony Brook, New Hyde Park +54 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: All ages

Code: NCT01790152·Recruiting·Listed Feb 2013

Apply to this trial

Testing a Brief Motivational Intervention to Increase Physical Activity for Cancer Survivors

for Cancer

1 location in Stony Brook

Sponsor: Stony Brook University

Sex: All·Age: All ages

Code: NCT07215091·Recruiting·Listed Oct 2025

Apply to this trial

Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer

for Breast Cancer

1 location in Stony Brook

Sponsor: Alison Stopeck

Sex: Female·Age: 18+

Code: NCT06220214·EARLY_Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

Definitive Radiation for High-Risk Spine Metastases

for Metastatic Cancer

1 location in Stony Brook

Sponsor: Stony Brook University

Sex: All·Age: 18+

Code: NCT06165419·Phase 2·Recruiting·Listed Dec 2023

Apply to this trial

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

for Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

Sites in Stony Brook +62 more locations

Sponsor: NRG Oncology

Sex: All·Age: 18+

Code: NCT07441681·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

for Endometrial Cancer

Sites in Stony Brook, White Plains +65 more locations

Sponsor: AstraZeneca

Sex: Female·Age: 18+

Code: NCT07044336·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for Breast Cancer

Drug: Durvalumab

Sites in Stony Brook, New York +34 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06103864·Phase 3·Recruiting·Listed Oct 2023

Apply to this trial

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for Non-Small Cell Lung Cancer

Drug: Rilvegostomig

Sites in Stony Brook +48 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06357533·Phase 3·Recruiting·Listed Apr 2024

Apply to this trial

Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

for Advanced Breast Cancer

Drug: Camizestrant

Sites in Stony Brook, Mineola +36 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06380751·Phase 3·Recruiting·Listed Apr 2024

Apply to this trial

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

for Multiple Myeloma

Drug: Belantamab mafodotin

Sites in Stony Brook, New York +28 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06679101·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

Oncology Clinical Trials in Stony Brook, NY

53 clinical trials for Oncology

Conditions in Oncology (Stony Brook, NY)